Myelofibrosis patients in Belgium: disease characteristics.

Timothy Devos, P. Zachee, D. Bron, L. Noens, Jan Van Droogenbroeck, P. Mineur, Yves Beguin, Zwi Berneman, Fs Benghiat, A. Kentos, C. Chatelain, H. Demuynck, J. Lemmens, Kg Eygen, Koen Theunissen, Fabienne Trullemans, P. Pierre, W. Pluymers, Laurent Knoops

Research output: Contribution to journalArticle

6 Citations (Scopus)


Objective: To date, only a small number of epidemiological studies on myelofibrosis have been performed. The current study aimed to characterize the myelofibrosis patient population in Belgium according to pre-defined disease parameters (diagnosis, risk categories, hemoglobin 50.000/µl and 201 (80%) had platelet count >100.000/µl. Of 250 patients, 85 (34%) had a myeloblast count >1%. Six (2%) patients had undergone a splenectomy. Thirteen (5* 2%) patients had undergone radiotherapy for splenomegaly. Conclusions: The results of this survey provide insight into the characteristics of the Belgian myelofibrosis population. They also suggest that a large proportion of these patients could stand to benefit from the therapies currently under development.
Original languageEnglish
Pages (from-to)105-111
JournalActa Clin Belg
Issue number2
Early online date6 Nov 2014
Publication statusPublished - Apr 2015


  • Myelofibrosis

Fingerprint Dive into the research topics of 'Myelofibrosis patients in Belgium: disease characteristics.'. Together they form a unique fingerprint.

Cite this